The Role of Chronic Disease in Superdisintegrant Demand
The increasing prevalence of chronic diseases like diabetes and cardiovascular conditions is indirectly driving the demand for superdisintegrants. Why? Because patients need easy-to-use, effective oral medications they can take regularly without discomfort. ODTs meet this need—and superdisintegrants make them possible. As more pharmaceutical companies recognize the patient adherence challenge, we’ll likely see a surge in new formulations that rely on advanced disintegration technology.To Get a PDF Sample Copy of the Report, visit @ https://www.emergenresearch.com/request-sample/4308
4 visualizzazioni